Delineating the Transcriptional Mechanisms in Immunity behind Allergy and 
Asthma: Milestones and Challenges Ahead

Cauchy, Pierre

doi:10.29011/IJAA-101

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Delineating the Transcriptional Mechanisms in Immunity behind Allergy and Asthma: Milestones and Challenges Ahead

MPS-Authors

/persons/resource/persons204283

Cauchy, Pierre
Department of Cellular and Molecular Immunology, Max Planck Institute of Immunobiology and Epigenetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Cauchy, P. (2017). Delineating the Transcriptional Mechanisms in Immunity behind Allergy and Asthma: Milestones and Challenges Ahead. International Journal of Allergy & Asthma, 1-15. doi:10.29011/IJAA-101.

Cite as: https://hdl.handle.net/21.11116/0000-0000-C15D-E

Abstract

Allergy and asthma have roots in imbalances in immune cell homeostasis, namely a shift towards T-helper 2 (T_)h2)-driven increases of Immunoglobulin E (IgE) immunity. Here, we describe the transcriptional processes that lead to the emergence of the immunological actors of allergy and asthma, i.e. T_h2, type 2 Innate Lymphoid Cells (ILC2), mast, IgE plasma and regulatory T-cells (_reg), as well as to the advent of imbalances towards T_h2 responses in pathological cases. We review in detail the latest advance in terms of genome-wide characterisation of the transcriptional landscapes of the protagonists of allergy and asthma, both in norma and pathological contexts if available, as well as a summary of current clinical approaches and discuss the requirement for further functional-based genome-wide characterisation of mechanisms that can lead to the attenuation of these conditions.